v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Operating activities:    
Net loss $ (7,874) $ (3,849)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 5,814 9,089
Bad debt expense 363 602
Stock-based compensation expense 24,398 22,577
Amortization of operating lease right-of-use assets 4,265 4,611
Other, net 481 184
Changes in operating assets and liabilities:    
Accounts receivable 62,021 54,943
Prepaid expenses and other current assets (3,231) (538)
Costs to obtain revenue contracts 7,619 6,554
Other long term assets 215 726
Accounts payable, accrued expenses and other current liabilities (4,649) (14,158)
Unearned revenue (56,370) (55,324)
Operating lease liabilities (5,742) (5,848)
Other long term liabilities 350 141
Net cash provided by operating activities 27,660 19,710
Investing activities:    
Capital expenditures (1,192) (1,567)
Net cash used in investing activities (1,192) (1,567)
Financing activities:    
Proceeds from exercise of stock options 791 8,610
Repurchase of common stock (201) (10,996)
Payments for taxes related to net share settlement of stock-based compensation awards (3,781) (7,750)
Payments of deferred financing costs (659) (301)
Proceeds, net from employee stock purchase plan withholdings 1,842 2,176
Net cash used in financing activities (2,008) (8,261)
Effect of exchange rate changes on cash and cash equivalents 179 431
Net increase in cash and cash equivalents 24,639 10,313
Cash and cash equivalents at beginning of period 210,184 190,214
Cash and cash equivalents at end of period $ 234,823 $ 200,527

Source

HTML PDF
ZIP